A new study found that weight-loss medications like Ozempic and Mounjaro are not as effective in a “real-world” setting ...

For patients with obesity initiating pharmacotherapy with semaglutide or tirzepatide, weight loss at one year is 8.7 percent ...

Women who use an oral contraceptive might want to consider using a back-up method after starting a weight loss drug.

Researchers have identified the brain cells responsible for the weight-loss effects of semaglutide without triggering its undesirable side effects. This discovery paves the way for more targeted ...

Experts say that semaglutide and tirzepatide can help patients with heart failure lose weight, but limited NHS access is ...

Novo Nordisk’s drugs are being linked to an eye condition that can cause vision loss, while health tech companies made CNBC’s ...

Real-world results for blockbuster weight-loss meds like Ozempic, Wegovy and Zepbound aren't as impressive as those promised ...

A new study published in The Lancet journal showed that patients with type 2 diabetes and symptomatic peripheral arterial ...

Srikakulam: In a serious breach of supply chain and internal controls, a group of eight individuals, including current and ...

Compounded GLP-1s are still accessible on telehealth sites, despite an agreement with Eli Lilly to cease copycat sales.

In a 36-week study, semaglutide was found to aid in weight loss for people with schizophrenia without worsening psychotic ...

Novo Nordisk is progressing both subcutaneous and oral versions of amycretin into Phase III trials for patients with obesity ...